Article Details
Retrieved on: 2025-03-06 19:49:56
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Biocon Ltd's partnership with Civica Inc to improve accessibility and affordability of insulin aspart in the US, aligning with biotechnology themes like recombinant proteins and peptide therapeutics. The collaboration highlights Biocon’s role in biopharmaceutical innovation.
Article found on: www.cnbctv18.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here